These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2824217)

  • 1. Effects of synthetic omega-conotoxin, a new type Ca2+ antagonist, on frog and mouse neuromuscular transmission.
    Sano K; Enomoto K; Maeno T
    Eur J Pharmacol; 1987 Sep; 141(2):235-41. PubMed ID: 2824217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium channels coupled to neurotransmitter release at neonatal rat neuromuscular junctions.
    Rosato Siri MD; Uchitel OD
    J Physiol; 1999 Jan; 514 ( Pt 2)(Pt 2):533-40. PubMed ID: 9852333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by neosurugatoxin and omega-conotoxin of acetylcholine release and muscle and neuronal nicotinic receptors in mouse neuromuscular junction.
    Hong SJ; Tsuji K; Chang CC
    Neuroscience; 1992; 48(3):727-35. PubMed ID: 1318519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium channels involved in synaptic transmission at the mature and regenerating mouse neuromuscular junction.
    Katz E; Ferro PA; Weisz G; Uchitel OD
    J Physiol; 1996 Dec; 497 ( Pt 3)(Pt 3):687-97. PubMed ID: 9003554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Ca2+ channel blockers on transmitter release and presynaptic currents at the frog neuromuscular junction.
    Katz E; Ferro PA; Cherksey BD; Sugimori M; Llinás R; Uchitel OD
    J Physiol; 1995 Aug; 486 ( Pt 3)(Pt 3):695-706. PubMed ID: 7473230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Ca2+ channel blocker neurotoxins on transmitter release and presynaptic currents at the mouse neuromuscular junction.
    Katz E; Protti DA; Ferro PA; Rosato Siri MD; Uchitel OD
    Br J Pharmacol; 1997 Aug; 121(8):1531-40. PubMed ID: 9283685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of omega-conotoxin GVIA on neurotransmitter release at the mouse neuromuscular junction.
    Protti DA; Szczupak L; Scornik FS; Uchitel OD
    Brain Res; 1991 Aug; 557(1-2):336-9. PubMed ID: 1684129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. omega-Conotoxin reduces facilitation of transmitter release at the frog neuromuscular junction.
    Zengel JE; Sosa MA; Poage RE
    Brain Res; 1993 May; 611(1):25-30. PubMed ID: 8100174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of synthetic omega-conotoxin on synaptic transmission.
    Koyano K; Abe T; Nishiuchi Y; Sakakibara S
    Eur J Pharmacol; 1987 Mar; 135(3):337-43. PubMed ID: 3034633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinergic agonists decrease quantal output at the frog neuromuscular junction by targeting a calcium channel blocked by omega-conotoxin.
    Van der Kloot W; Molgó J; Naves LA
    Pflugers Arch; 1997 Nov; 434(6):735-41. PubMed ID: 9306006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential blockade by nifedipine and omega-conotoxin GVIA of alpha 1- and beta 1-adrenoceptor-controlled calcium channels on motor nerve terminals of the rat.
    Wessler I; Dooley DJ; Osswald H; Schlemmer F
    Neurosci Lett; 1990 Jan; 108(1-2):173-8. PubMed ID: 2154721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-conotoxin GVIA blocks synaptic transmission in the CA1 field of the hippocampus.
    Dutar P; Rascol O; Lamour Y
    Eur J Pharmacol; 1989 Dec; 174(2-3):261-6. PubMed ID: 2560980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium-independent increase of transmitter release at frog end-plate by trinitrobenzene sulphonic acid.
    Kijima H; Tanabe N
    J Physiol; 1988 Sep; 403():135-49. PubMed ID: 3150982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The upregulation of acetylcholine release at endplates of alpha-bungarotoxin-treated rats: its dependency on calcium.
    Plomp JJ; van Kempen GT; Molenaar PC
    J Physiol; 1994 Jul; 478 ( Pt 1)(Pt 1):125-36. PubMed ID: 7965828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of mu-conotoxin GIIIA for the study of synaptic transmission at the frog neuromuscular junction.
    Sosa MA; Zengel JE
    Neurosci Lett; 1993 Jul; 157(2):235-8. PubMed ID: 8233060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postsynaptic block of frog neuromuscular transmission by conotoxin GI.
    McManus OB; Musick JR
    J Neurosci; 1985 Jan; 5(1):110-6. PubMed ID: 2981295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of specific 125I-omega-conotoxin GVIA binding and 125I-omega-conotoxin GVIA labeling using bifunctional crosslinkers in crude membranes from chick whole brain.
    Ichida S; Wada T; Akimoto T; Kasamatsu Y; Tahara M; Hasimoto K
    Biochim Biophys Acta; 1995 Jan; 1233(1):57-67. PubMed ID: 7833350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postsynaptic inhibition of the frog neuromuscular transmission by prostaglandin E1.
    Tsurusaki M; Tokimasa T; Akasu T
    Neurosci Lett; 1987 Jun; 77(3):303-7. PubMed ID: 3039417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lead on neuromuscular transmission in the frog.
    Manalis RS; Cooper GP; Pomeroy SL
    Brain Res; 1984 Feb; 294(1):95-109. PubMed ID: 6320979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic omega-conotoxin blocks synaptic transmission in the hippocampus in vitro.
    Kamiya H; Sawada S; Yamamoto C
    Neurosci Lett; 1988 Aug; 91(1):84-8. PubMed ID: 2845309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.